The antibody itself, nacolomab, is fused with enterotoxin A from Staphylococcus aureus (which is reflected by 'tafenatox' in the drug's name).
Nacolomab, an antibody, incorporates enterotoxin A from Staphylococcus aureus (referred to as 'tafenatox' in the drug's designation).